Title Page / Table of Contents.
- Published in:
- 2005
- Publication type:
- Table of Contents
Works matching IS 16602854 AND DT 2005 AND VI 2 AND IP 3/4
Results: 17
1
2
Preface.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 113, doi. 10.1159/000089615
- By:
- Publication type:
- Article
3
Mutant SOD1 Instability: Implications for Toxicity in Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 115, doi. 10.1159/000089616
- By:
- Publication type:
- Article
4
Inter- and Intracellular Signaling in Amyotrophic Lateral Sclerosis: Role of p38 Mitogen-Activated Protein Kinase.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 128, doi. 10.1159/000089617
- By:
- Publication type:
- Article
5
Anti-ALS Activity of Alsin, the Product of the ALS2 Gene, and Activity-Dependent Neurotrophic Factor.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 135, doi. 10.1159/000089618
- By:
- Publication type:
- Article
6
Complexity of Astrocyte-Motor Neuron Interactions in Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 139, doi. 10.1159/000089619
- By:
- Publication type:
- Article
7
Excitotoxicity and Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 147, doi. 10.1159/000089620
- By:
- Publication type:
- Article
8
Enprofylline Protects Motor Neurons from in vitro Excitotoxic Challenge.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 160, doi. 10.1159/000089621
- By:
- Publication type:
- Article
9
Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 166, doi. 10.1159/000089622
- By:
- Publication type:
- Article
10
Amyotrophic Lateral Sclerosis: New Developments in Diagnostic Markers.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 177, doi. 10.1159/000089623
- By:
- Publication type:
- Article
11
Reticulons as Markers of Neurological Diseases: Focus on Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 185, doi. 10.1159/000089624
- By:
- Publication type:
- Article
12
Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 195, doi. 10.1159/000089625
- By:
- Publication type:
- Article
13
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 202, doi. 10.1159/000089626
- By:
- Publication type:
- Article
14
Clinical Trials in ALS: What Did We Learn from Recent Trials in Humans?
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 208, doi. 10.1159/000089627
- By:
- Publication type:
- Article
15
Preclinical Trials – An Update on Translational Research in ALS.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 215, doi. 10.1159/000089628
- By:
- Publication type:
- Article
16
Promises and Challenges in Developing RNAi as a Research Tool and Therapy for Neurodegenerative Diseases.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 220, doi. 10.1159/000089629
- By:
- Publication type:
- Article
17
Author and Subject Index.
- Published in:
- Neurodegenerative Diseases, 2005, v. 2, n. 3/4, p. 232, doi. 10.1159/000090900
- Publication type:
- Article